Navigation Links
Ribonuclease in Medical Technology

Alfacell Provides Shareholder Update

... Chief Operating Officer About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Provides ONCONASE(R) NDA Submission Update

... submission of its NDA. About ONCONASE (R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines

... role in treating the disease." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel

... with Megapharm." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial

... Web site at http://www.alfacell.com . About ONCONASE(R) ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment

... in, and confounds the treatment of NSCLC." About ONCONASE(R) ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R)

... and to bring them forward into the clinic." About ONCONASE(R) ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program

... and receive at least one dose of study drug. About ONCONASE(R) ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Reports Financial Results for First Quarter of Fiscal 2008

... site at http://www.alfacell.com . About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program

... to discuss the company's fiscal 2007 performance. About ONCONASE(R) ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress

... diseases, atherosclerosis and septic shock." About ONCONASE(R) ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Alfacell's Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies

... href= "http://www.wiley.com/">http://www.wiley.com . About ONCONASE(R) ONCONASE is a first-in-class therapeutic based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's Onconase

... About ONCONASE(R) ONCONASE is a first-in-class therapeutic based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

In vivo Study Results Demonstrating Potential of Alfacell's Onconase for Treatment of Non-Small Cell Lung Cancer Published in Anticancer Research

... areas and via multiple treatment modalities." About ONCONASE(R) ONCONASE is a first-in-class therapeutic based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Researchers Identify Intracellular Pathway of Alfacell's Onconase

... for our technology platform." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells

... preclinical and clinical studies." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting

... the potential uses of ONCONASE." About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...

In Vitro and In Vivo Data Show Alfacell's Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells

... neuroblastoma in the United States. About ONCONASE(R) ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells ...
Other Contents
(Date:8/27/2014)... cells to rearrange existing patterns of activity than when ... study of monkeys has found. The scientists explored the ... of brain cell networks. The study was partly funded ... into the brain and may have seen why it,s ... Batista, Ph.D., an assistant professor at the University of ...
(Date:8/27/2014)... want to listen carefully to someone, the first thing ... do is stop moving altogether. This strategy helps us ... own movements. , This interplay between movement and hearing ... indirect evidence has long suggested that the brain,s motor ... which gives rise to our conscious perception of sound. ...
(Date:8/27/2014)... in German . ... common inherited disease affecting the peripheral nervous system. Researchers ... Institute of Experimental Medicine and University Medical Centre Gttingen ... impaired in rats with the disease. These cells enwrap ... myelin, which facilitates the rapid transfer of electrical impulses. ...
Breaking Biology News(10 mins):Scientists plug into a learning brain 2Scientists plug into a learning brain 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Potential therapy for incurable Charcot-Marie-Tooth disease 2
(Date:8/28/2014)... Baltimore Business Journal released rankings of the ... The Canton Group with the number one spot. ... Group is the largest firm in Baltimore, generating $11.75 ... education, health care, nonprofits, associations, and state and federal ... and web development projects that a lot of companies ...
(Date:8/28/2014)... A leading Florida mental health program ... a result of media coverage surrounding Robin Williams’ death. When ... ‘copycat suicides’ among the general public. The Sylvia Brafman Mental ... what happened—the suicide itself—but on what we can do to ... is a tragedy on so many counts,” said Ben Brafman, ...
(Date:8/28/2014)... In the healthcare industry, there is one primary ... can the overall quality of patient care be improved? ... industry tackles this question, and has collected data that ... the quality of patient care. , Results ... Factors related to Improving Quality of Patient Care: Technical ...
(Date:8/28/2014)... Roswell, GA (PRWEB) August 28, 2014 ... its new alliance with Gigya, the leader in ... Login” product, Tea Leaves will have the opportunity ... by finding out who they are and how ... Management Suite enables the world’s biggest brands to ...
(Date:8/28/2014)... August 28, 2014 MarijuanaDoctors.com is enthralled ... James Patel M.D. of Livermore, California. As always, MarijuanaDoctors.com ... most qualified physicians, and in accordance with that, we ... to Dr. Patel’s practice. , Initially finding his calling ... age, Dr. Patel was shaped by his mother’s severe ...
Breaking Medicine News(10 mins):Health News:The Canton Group is Recognized by the Baltimore Business Journal as the Largest Web Design Firm in Baltimore 2Health News:Sylvia Brafman Mental Health Center Warns of Suicide Contagion Following Robin Williams’ Death 2Health News:New Healthcare Study Explores Strategies for Improving Patient Care 2Health News:New Healthcare Study Explores Strategies for Improving Patient Care 3Health News:New Healthcare Study Explores Strategies for Improving Patient Care 4Health News:Tea Leaves Health Begins Important New Partnership with Gigya 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4
Other TagsOther Tags